100 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MA
Investor Presentation
News, Articles of Incorporation
Changes in Board, Management or Compensation
News, Legal Opinion, Material Contracts
Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors
Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
Enters into Exclusive Global License Agreement for Late-Stage Autoimmune Asset
Q2
Q1
FY 2024
Q3
Q2 amended
FY 2023
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities